Cargando…

The Landscape of Nucleic-Acid-Based Aptamers for Treatment of Hematologic Malignancies: Challenges and Future Directions

Hematologic malignancies, including leukemia, lymphoma, myeloproliferative disorder and plasma cell neoplasia, are genetically heterogeneous and characterized by an uncontrolled proliferation of their corresponding cell lineages in the bone marrow, peripheral blood, tissues or plasma. Although there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Si Chun, Yan, Xing Yi, Yang, Chang, Naranmandura, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687288/ https://www.ncbi.nlm.nih.gov/pubmed/36354547 http://dx.doi.org/10.3390/bioengineering9110635

Ejemplares similares

Nucleic Acid Aptamers in Nanotechnology
por: Sinitsyna, Valentina V., et al.
Publicado: (2022)

The Research Advances of Aptamers in Hematologic Malignancies
por: Liao, Yongkang, et al.
Publicado: (2023)

Selective Targeting to Glioma with Nucleic Acid Aptamers
por: Aptekar, Shraddha, et al.
Publicado: (2015)

Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
por: Fu, Zhaoying, et al.
Publicado: (2020)

Recent Progress and Opportunities for Nucleic Acid Aptamers
por: Byun, Jonghoe
Publicado: (2021)

Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies
por: Yang, Shuanghui, et al.
Publicado: (2018)

Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing
por: Ku, Ti-Hsuan, et al.
Publicado: (2015)

Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
por: Tang, Lu, et al.
Publicado: (2023)

Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
por: Ni, Shuaijian, et al.
Publicado: (2017)

Nucleic acid aptamer-based methods for diagnosis of infections
por: Park, Ki Soo
Publicado: (2018)

Therapeutic applications of nucleic acid aptamers in microbial infections
por: Afrasiabi, Shima, et al.
Publicado: (2020)

Exploiting the Nucleic Acid Nature of Aptamers for Signal Amplification
por: Jauset-Rubio, Miriam, et al.
Publicado: (2022)

Targeting macrophages in hematological malignancies: recent advances and future directions
por: Li, Wei, et al.
Publicado: (2022)

Strategies for developing long-lasting therapeutic nucleic acid aptamer targeting circulating protein: The present and the future
por: Zhang, Yihao, et al.
Publicado: (2022)

The landscape overview of CD47-based immunotherapy for hematological malignancies
por: Yang, Hua, et al.
Publicado: (2023)

Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma
por: Shum, Ka-To, et al.
Publicado: (2013)

Recent Progress in Nucleic Acid Aptamer-Based Biosensors and Bioassays
por: Mok, Wendy, et al.
Publicado: (2008)

Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
por: Santosh, Baby, et al.
Publicado: (2014)

Molecular dynamics study of the recognition of ATP by nucleic acid aptamers
por: Xie, Ya-chen, et al.
Publicado: (2020)

Splitting aptamers and nucleic acid enzymes for the development of advanced biosensors
por: Debiais, Mégane, et al.
Publicado: (2020)

The DNA methylation landscape of hematological malignancies: an update
por: Blecua, Pedro, et al.
Publicado: (2020)

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
por: Lamb, Margaret G., et al.
Publicado: (2021)

Amino acids in hematologic malignancies: Current status and future perspective
por: Wang, Mengyao, et al.
Publicado: (2023)

Nucleic Acid Aptamers Emerging as Modulators of G-Protein-Coupled Receptors: Challenge to Difficult Cell Surface Proteins
por: Takahashi, Masaki
Publicado: (2022)

Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics
por: Vorhies, John S, et al.
Publicado: (2007)

Nucleic-Acid-Binding Chromophores as Efficient Indicators of Aptamer-Target Interactions
por: Sarpong, Kwabena, et al.
Publicado: (2012)

Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option
por: Catuogno, Silvia, et al.
Publicado: (2018)

An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
por: Roueinfar, Mina, et al.
Publicado: (2022)

Repurposing of thermally stable nucleic-acid aptamers for targeting tetrodotoxin (TTX)
por: Li, Yuanyuan, et al.
Publicado: (2022)

Nucleic Acid Aptamers: New Methods for Selection, Stabilization, and Application in Biomedical Science
por: Kong, Hoon Young, et al.
Publicado: (2013)

Radiolabeling of Nucleic Acid Aptamers for Highly Sensitive Disease-Specific Molecular Imaging
por: Hassanzadeh, Leila, et al.
Publicado: (2018)

Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers
por: Mercier, Marie-Cécile, et al.
Publicado: (2017)

Nucleic Acid Aptamer: A Novel Potential Diagnostic and Therapeutic Tool for Leukemia
por: Tan, Yuan, et al.
Publicado: (2019)

Nucleic Acid Aptamers for Molecular Therapy of Epilepsy and Blood-Brain Barrier Damages
por: Zamay, Tatiana N., et al.
Publicado: (2019)

Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
por: Hocking, Jay, et al.
Publicado: (2016)

Cognitive Impairment in Heart Failure: Landscape, Challenges, and Future Directions
por: Yang, Mengxi, et al.
Publicado: (2022)

Structural transformation induced by locked nucleic acid or 2′–O-methyl nucleic acid site-specific modifications on thrombin binding aptamer
por: Liu, Bo, et al.
Publicado: (2014)

The Challenge of Targeting Notch in Hematologic Malignancies
por: Hernandez Tejada, Fiorela N., et al.
Publicado: (2014)

Rapid One-Step Selection Method for Generating Nucleic Acid Aptamers: Development of a DNA Aptamer against α-Bungarotoxin
por: Lauridsen, Lasse H., et al.
Publicado: (2012)

Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer
por: Pasternak, Anna, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_f44jbin98udsl3dnm0qr20624t